ST. PAUL, Minn.--(BUSINESS WIRE)--
St. Jude Medical, Inc. (STJ), a global medical device company, today reported sales and net earnings for the second quarter ended July 2, 2016.
Second quarter 2016 highlights:
Net sales of $1.562 billion increased 11 percent as reported, or 2 percent on a comparable constant currency basis.
International sales increased 10 percent as reported, or 7 percent on a comparable constant currency basis where a full portfolio of products is available.
Neuromodulation sales increased 19 percent as reported, or 20 percent on a constant currency basis driven by the most comprehensive product portfolio on the market.
Atrial fibrillation sales increased 13 percent as reported and on a constant currency basis driven by strong growth across the product portfolio.
